Evidence-Based Approach
Beijing Biotech network
Beijing Biotech is based in Beijing, China and works with hospitals in:
How we support international families (trust elements):
We understand that traveling abroad for advanced cellular therapies can feel overwhelming. Our role is to provide structured, transparent coordination so families can focus on care decisions with confidence.
We support the full pre-treatment preparation process by:
Collecting and organizing medical records
Preparing structured case summaries for hospital review
Mapping a clear treatment timeline in alignment with the treating hospital team
Where applicable and program-dependent, we support:
GMP-aligned quality systems
Standardized documentation processes
Chain-of-identity and chain-of-custody support for cellular workflows
Our focus is maintaining process integrity, traceability, and clear documentation throughout the coordination pathway.
Advanced therapies often require input from multiple specialties. We help coordinate:
Oncology and hematology consultations
Imaging and diagnostic scheduling
Laboratory testing logistics
Supportive care planning discussions
This structured alignment helps ensure that all required evaluations are completed in a timely and organized manner.
Care does not end at discharge. We facilitate collaboration pathways with hospitals and oncology teams worldwide to support:
Structured medical summaries for handoff
Clear follow-up planning
Communication continuity with your home medical team
Our goal is to help ensure a smooth transition back to your local physicians for ongoing monitoring and care.
Do you have a dedicated cell therapy or hematology team for my diagnosis?
A reputable center should have a specialized multidisciplinary team experienced in your specific condition (such as leukemia or lymphoma). This typically includes:
Hematologists/oncologists
Cellular therapy specialists
Critical care physicians
Trained nursing staff
Pharmacists and supportive care teams
Experience with cellular immunotherapy programs is essential for safe delivery and complication management.
How is eligibility determined?
Eligibility should be based on defined medical and protocol criteria, which may include:
Clinical trial inclusion/exclusion criteria (if applicable)
Organ function testing (heart, liver, kidney function)
Infection screening
Disease status and prior treatment history
Overall performance status
A qualified center will conduct a thorough medical review before confirming candidacy.
What is the monitoring plan for fever, low blood pressure, or neurologic symptoms?
Cellular therapies can trigger immune-related reactions. A hospital should provide a clear monitoring plan that includes:
Standardized protocols for early detection of side effects
Continuous vital sign monitoring when required
Defined intervention pathways
Access to medications and supportive care for immune-related toxicities
Patients should understand how symptoms are recognized and managed.
Do you have ICU access and a clear escalation pathway?
A properly equipped center should have:
Immediate access to an Intensive Care Unit (ICU)
A documented escalation protocol for severe reactions
Staff trained in managing cytokine-related toxicities and neurologic complications
Clear escalation planning is a critical safety component.
Can you provide clear consent documentation (English or certified translation)?
Informed consent should be:
Written in clear, understandable language
Available in English or provided with certified translation
Inclusive of risks, potential benefits, alternatives, and uncertainties
Transparency is essential in advanced cellular therapy programs.
How do you document chain-of-identity, chain-of-custody, and product release testing?
Cellular therapies require strict quality control. A qualified program should:
Maintain documented chain-of-identity from cell collection to infusion
Follow chain-of-custody tracking procedures
Perform required release testing before administration
Operate under established quality systems (such as GMP-aligned processes, program-dependent)
These safeguards help ensure product integrity and patient safety.